Background Objective attainment of guideline-recommended low-density lipoprotein cholesterol (LDL-C) is usually suboptimal. and 52.2% of individuals, respectively). Two times atorvastatin dose was commonly recommended in all scenarios (43C52% of buy TCS 1102 individuals). More rigorous LDL-C-lowering regimens were recommended infrequently e.g. double atorvastatin dose add ezetimibe only